1Mukai M,Bohgaki T.Notoya A,et al.Liver dyslunction due to apoptosis in a patient with systemie Inpus erythemutosus[J].Lupus,2000,9(1):74-77.
2Ohira II.Tukiguchi J.Rui T,et al.High frequency of anti-ribosomal P antibody in patients with systemic lupus erythematosus-associated hepatitis[J].Hepatology Hesearch,2004,28(2):137-139.
4Sitipaitoon B.Osiri M,Vongthavaravat V,et al.The prvalence of dyslipoproteincmia in Thai patients with systemic lupus erythematosus[J].Lupus,2004,13(12):961-968.
5hcikh Z,Ahmad R,Sheikh N,et al.Enhanced recognition of reactive oxygen species damaged human serum albumin by circulating systemic lupus crythematosus autoantbodies[J].Autoimmunity,2007,40(7):512-520.
二级参考文献8
1Nuttall SL,Heaton S,Piper MK,et al.Cardiovascular risk in systemic lupus erythematosus-evidence of increased oxidative stress and dyslipidaemia[J].Rheumatology,2003,42 (6):758-762.
2Carlk WF,Moist LM.Management of chronic renal insufficiency in lupus nephritis:Role of proteinuria,hypertension and dyslipidemia in the progression of renal disease[J].Lupus,1998,7 (9):649-653.
3Borba EF,Bonfa E,Dyslipoproteinemias in systemic lupus erythematosus:influence of disease activity and anticardiolipin antibodies[J].Lupus,1997,6(6):553 -559.
4Formiga F,Meco JF,Pinto X,et al.Lipid and lipoprotein levels in premenopa-usal systemic lupus erythematosus patients[J].Lupus,2001,10(5):359 -363.
5Delgado Alves J,Ames PR,Donohue S,et al.Antibodies to high-density lipoprotein and beta2-glycoprotein are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome[J].Arthritis Rheum,2002,46 (10):2686-2694.
6Siripaitoon B,Osiri M,Vongthavaravat V,et al.The prevalence of dyslipo-proteinemia in Thai patients with systemic lupus erythematosus[J].Lupus,2004,13 (12):961-968.
